Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020 Revenues of Operating Division Increase by 50.4% NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) The global leader in blood volume technology today filed its Annual...

Global Technologies, Ltd Update on Corporate Operations Company Fully Reporting with Securities and Exchange Commission ST. PETERSBURG, FL, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Global Technologies, Ltd (OTC Pink: GTLL), a holding corporation, which...

Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019 NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...